This event was the first time the OECD has taken a systematic look at what marine biotechnology could contribute to the grand challenges of food and fuel security, population health, green growth and sustainable industries.
Across OECD countries some 83 million people suffer from diabetes. On current trends, that will rise to almost 100 million by 2030.
English, , 2,854kb
Background document to the European Diabetes Leadership Forum (EDLF) in Copenhagen, 25-26 April 2012.
English, , 429kb
This guide comprises eight key points for planning public engagement activities. It contains a set of questions to help policy makers develop a plan from start to finish, as well as practical case studies from countries that have used the guide in their communication activities.
At a time when ever more information is available about the quality of health care, the challenge for policy makers is to better understand the policies and approaches that sit behind the numbers. Korea is the first country report in a new OECD series evaluating the quality of health care across OECD countries – whether care is safe, effective and responsive to patients’ needs. OECD Reviews of Health Care Quality examine
The European Diabetes Leadership Forum (EDLF), to be held in Copenhagen on 25-26 April 2012, is hosted by the OECD and the Danish Diabetes Association.
A new OECD series of Health Care Quality Reviews opens with a review of Korea.
OECD and the European Observatory on Heath Systems and Policies joined forces to conduct a study on the economics of public health and health promotion.
More people in developed countries are overweight or obese than ever before, dooming them to years of ill-health and early death. New OECD data show however that in some countries obesity rates are slowing, and that’s good news for people’s health and government budgets.
This forum explored topics such as regulatory considerations, skills and research support, intellectual property and community engagement. In addition, discussions will also focus on links between a ‘bioeconomy’ and synthetic biology.